Foghorn Therapeutics (FHTX) Price Target Cut to $5 After Program Halt
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has reduced the price target for Foghorn Therapeutics (FHTX) to $5 following a halt in one of its programs. This adjustment reflects concerns over the company's prospects in the market after the program's interruption. The move signals a shift in analyst sentiment, potentially influencing investor confidence and stock performance. For ordinary investors, this means adjusted expectations for Foghorn's stock value, which could impact investment decisions.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
